Erythromycin-benzoyl Peroxide
NDC Package 45802-083-86

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Erythromycin-benzoyl Peroxide is a medication used to treat moderate acne. Marketed by Perrigo New York Inc, this product is identified by NDC 45802-083 and is authorized under FDA application NDA050557.

Identification & Billing

NDC Package Code
45802-083-86
Package Description
1 KIT in 1 BOX * 1.6 g in 1 VIAL, PLASTIC * 40 g in 1 JAR
Product Code
45802-083
11-Digit Billing Format
45802008386
Billing Unit
GM - Billing unit of "gram" is used when a product is measured by its weight.

Clinical Specifications

Proprietary Name
Erythromycin-benzoyl Peroxide
Dosage Form
-
Usage Information
This product is used to treat moderate acne. It helps to reduce the number of pimples. This medication is a combination of 2 drugs. Erythromycin works by stopping the growth of acne-causing bacteria. It belongs to a class of drugs known as macrolide antibiotics. Benzoyl peroxide also kills acne-causing bacteria and causes the top layer of skin to dry and peel off so that new skin can form. This product also contains alcohol which helps to dry extra oils from the skin.

Regulatory & Marketing

Labeler Name
Perrigo New York Inc
FDA Application #
NDA050557
Marketing Category
NDA AUTHORIZED GENERIC - A product marketed as a "generic" drug under an approved New Drug Application (NDA), rather than an Abbreviated New Drug Application (ANDA),.
Start Marketing Date
05-07-2013
End Marketing Date
01-01-2017
Listing Expiration
01-01-2017
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (45802-083). Click a package code to view its specific billing and regulatory data.

45802-083-02
1 KIT in 1 BOX * .8 g in 1 VIAL, PLASTIC * 20 g in 1 JAR

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 45802-083-86 identifies a specific commercial package of 1 kit in 1 box * 1.6 g in 1 vial, plastic * 40 g in 1 jar of Erythromycin-benzoyl Peroxide, labeled by Perrigo New York Inc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Perrigo New York Inc on May 07, 2013. The current certification is valid through January 01, 2017.

What are the primary indications for this medication?

This product is used to treat moderate acne. It helps to reduce the number of pimples. This medication is a combination of 2 drugs. Erythromycin works by stopping the growth of acne-causing bacteria. It belongs to a class of drugs known as macrolide antibiotics. Benzoyl peroxide also kills acne-causing bacteria and causes the top layer of skin to dry and peel off so that new skin can form. This product also contains alcohol which helps to dry extra oils from the skin.

How is this Perrigo New York Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 45802008386. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
45802-083-86
11-Digit CMS (5-4-2)
45802-0083-86

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.